Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer
- 1 June 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 253 (6), 1147-1154
- https://doi.org/10.1097/sla.0b013e318214b55a
Abstract
Background/Objective: This study attempted a national inventory of all bilateral prophylactic mastectomies performed in Sweden between 1995 and 2005 in high-risk women without a previous breast malignancy. The primary aim was to investigate the breast cancer incidence after surgery. Secondary aims were to describe the preoperative risk assessment, operation techniques, complications, histopathological findings, and regional differences. Methods: Geneticists, oncologists and surgeons performing prophylactic breast surgery were asked to identify all women eligible for inclusion in their region. The medical records were reviewed in each region and the data were analyzed centrally. The BOADICEA risk assessment model was used to calculate the number of expected/prevented breast cancers during the follow-up period. Results: A total of 223 women operated on in 8 hospitals were identified. During a mean follow-up of 6.6 years, no primary breast cancer was observed compared with 12 expected cases. However, 1 woman succumbed 9 years post mastectomy to widespread adenocarcinoma of uncertain origin. Median age at operation was 40 years. A total of 58% were BRCA1/2 mutation carriers. All but 3 women underwent breast reconstruction, 208 with implants and 12 with autologous tissue. Four small, unifocal, invasive cancers and 4 ductal carcinoma in situ were found in the mastectomy specimens. The incidence of nonbreast related complications was low (3%). Implant loss due to infection/necrosis occurred in 21 women (10%) but a majority received a new implant later. In total, 64% of the women underwent at least 1unanticipated secondary operation. Conclusions: Bilateral prophylactic mastectomy is safe and efficacious in reducing future breast cancer in asymptomatic women at high risk. Unanticipated reoperations are common. Given the small number of patients centralization seems justified.This publication has 45 references indexed in Scilit:
- Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation CarriersJournal of Clinical Oncology, 2010
- Oophorectomy for Breast Cancer Prevention in Women with Brca1 Or Brca2 MutationsWomen's Health, 2009
- Prophylactic oophorectomy in women at increased cancer riskCurrent Opinion in Obstetrics and Gynecology, 2007
- Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study GroupJournal of Clinical Oncology, 2004
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriersEuropean Journal of Cancer, 2002
- Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation CarriersJNCI Journal of the National Cancer Institute, 2001
- Breast Cancer after Prophylactic Bilateral Mastectomy in Women with aBRCA1orBRCA2MutationThe New England Journal of Medicine, 2001
- Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast CancerThe New England Journal of Medicine, 1999